Intranasal vaccination with adjuvant-free S. aureus antigens effectively protects mice against experimental sepsis

详细信息    查看全文

• 作者：Nataly Pescinalli Stegmiller^a ; Estevã ; o Carlos Barcelos^a ; Janine Miranda Leal^b ; Luciana Polaco Covre^b ; Dirlei Molinari Donatele^c ; Herbet Leonel de Matos Guedes^d ; Marco Cesar Cunegundes^a ; Rodrigo Ribeiro Rodrigues^b ; Daniel Clá ; udio Oliviera Gomes^a ; ^b ; ^{dgomes@ndi.ufes.br" class="auth_mail" title="E-mail the corresponding author}
• 关键词：Staphylococcus aureus ; Intranasal vaccination ; Sepsis
• 刊名：Vaccine
• 出版年：2016
• 出版时间：24 June 2016
• 年：2016
• 卷：34
• 期：30
• 页码：3493-3499
• 全文大小：1127 K

文摘

Staphylococcus aureus (S. aureus) is a Gram-positive coccal bacterium comprising part of the human skin, nares and gastrointestinal tract normal microbiota. It is also an important cause of nosocomial/community-acquired infections in humans and animals, which can cause a diverse array of infections, including sepsis, which is a progressive systemic inflammation response syndrome that is frequently fatal. The emergence of drug-resistant strains and the high toxicity of the treatments used for these infections point out the need to develop an effective, inexpensive and safe vaccine that can be used prophylactically. In this work, we used an experimental sepsis model to evaluate the effectiveness of whole antigens from S. aureus (SaAg) given by the intranasal route to induce protective immunity against S. aureus infection in mice. BALB/c mice were vaccinated via intranasal or intramuscular route with two doses of SaAg, followed by biocompatibility and immunogenicity evaluations. Vaccinated animals did not show any adverse effects associated with the vaccine, as determined by transaminase and creatinine measurements. Intranasal, but not intramuscular vaccination with SaAg led to a significant reduction in IL-10 production and was associated with increased level of IFN-γ and NO. SaAg intranasal vaccination was able to prime cellular and humoral immune responses and inducing a higher proliferation index and increased production of specific IgG1/IgG2, which contributed to decrease the bacterial load in both liver and the spleen and improve survival during sepsis. These findings present the first evidence of the effectiveness of whole Ag intranasal-based vaccine administration, which expands the vaccination possibilities against S. aureus infection.